|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hepatocellular carcinoma. Nat Rev Dis
Primers. 7:72021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang C, Zhang H, Zhang L, Zhu AX, Bernards
R, Qin W and Wang C: Evolving therapeutic landscape of advanced
hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol.
20:203–222. 2023. View Article : Google Scholar
|
|
4
|
Ramos S: Cancer chemoprevention and
chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr
Food Res. 52:507–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
García Rodríguez LA, Martín-Pérez M,
Hennekens CH, Rothwell PM and Lanas A: Bleeding risk with long-term
Low-dose aspirin: A systematic review of observational studies.
PLoS One. 11:e01600462016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laidlaw TM and Cahill KN: Current
knowledge and management of hypersensitivity to aspirin and NSAIDs.
J Allergy Clin Immunol Pract. 5:537–545. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren W, Wang W and Guo Y: Analysis of
adverse reactions of aspirin in prophylaxis medication based on
FAERS database. Computational Mathematical Methods Med.
2022:78822772022. View Article : Google Scholar
|
|
8
|
Anwanwan D, Singh SK, Singh S, Saikam V
and Singh R: Challenges in liver cancer and possible treatment
approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020.
View Article : Google Scholar :
|
|
9
|
Sayiner M, Golabi P and Younossi ZM:
Disease burden of hepatocellular carcinoma: A global perspective.
Dig Dis Sci. 64:910–917. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chopra B and Dhingra AK: Natural products:
A lead for drug discovery and development. Phytother Res.
35:4660–4702. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng C, Zhuo S, Zhang B, Zhao X, Liu Y,
Liao C, Quan J, Li Z, Bode AM, Cao Y and Luo X: Treatment
implications of natural compounds targeting lipid metabolism in
nonalcoholic fatty liver disease, obesity and cancer. Int J Biol
Sci. 15:1654–1663. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the nearly four decades from 01/1981
to 09/2019. J Nat Prod. 83:770–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP
and Wang YT: Terpenoids: Natural products for cancer therapy.
Expert Opin Investig Drugs. 21:1801–1818. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Atanasov AG, Zotchev SB, Dirsch VM;
International Natural Product Sciences Taskforce; Supuran CT:
Natural products in drug discovery: Advances and opportunities. Nat
Rev Drug Discov. 20:200–216. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Langhasova L, Hanusova V, Rezek J,
Stohanslova B, Ambroz M, Kralova V, Vanek T, Lou JD, Yun ZL, Yang J
and Skalova L: Essential oil from Myrica rubra leaves inhibits
cancer cell proliferation and induces apoptosis in several human
intestinal lines. Industrial Crops Products. 59:20–26. 2014.
View Article : Google Scholar
|
|
16
|
Wang J, Li X, Bai Z, Chi BX, Wei Y and
Chen X: Curcumol induces cell cycle arrest in colon cancer cells
via reactive oxygen species and Akt/GSK3β/cyclin D1 pathway. J
Ethnopharmacol. 210:1–9. 2018. View Article : Google Scholar
|
|
17
|
Barcellos Marini M, Rodrigues de Freitas
W, Lacerda da Silva Machado F, Correa Ramos Leal I, Ribeiro Soares
A, Masahiko Kanashiro M and Frazão Muzitano M: Cytotoxic activity
of halogenated sesquiterpenes from Laurencia dendroidea. Phytother
Res. 32:1119–1125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choo SJ, Ryoo IJ, Kim KC, Na M, Jang JH,
Ahn JS and Yoo ID: Hypo-pigmenting effect of sesquiterpenes from
Inula britannica in B16 melanoma cells. Arch Pharm Res. 37:567–574.
2014. View Article : Google Scholar
|
|
19
|
Liu W, Wang X, Sun J, Yang Y, Li W and
Song J: Parthenolide suppresses pancreatic cell growth by
autophagy-mediated apoptosis. Onco Targets Ther. 10:453–461. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Wang C, Wu Z, Xue J, Shen B, Zuo
W, Wang Z and Wang SL: Artesunate suppresses the growth of
prostatic cancer cells through inhibiting androgen receptor. Biol
Pharm Bull. 40:479–485. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mitsui T, Hayashi K, Kawai M, Kido M, Tani
H, Takaoka D, Matsuura N and Nozaki H: Culcitiolides E-J, six new
eremophilane-type sesquiterpene derivatives from Senecio
culcitioides. Chem Pharm Bull (Tokyo). 61:816–822. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ko W, Park JS, Kim KW, Kim J, Kim YC and
Oh H: Nardosinone-type sesquiterpenes from the hexane fraction of
Nardostachys jatamansi attenuate NF-κB and MAPK signaling pathways
in lipopolysaccharide-stimulated BV2 microglial cells.
Inflammation. 41:1215–1228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheikh IA, El-Baba C, Youssef A, Saliba
NA, Ghantous A and Darwiche N: Lessons learned from the discovery
and development of the sesquiterpene lactones in cancer therapy and
prevention. Expert Opin Drug Discov. 17:1377–1405. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matos MS, Anastácio JD and Nunes dos
Santos C: Sesquiterpene lactones: Promising natural compounds to
fight inflammation. Pharmaceutics. 13:9912021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Merfort I: Perspectives on sesquiterpene
lactones in inflammation and cancer. Curr Drug Targets.
12:1560–1573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hohmann MSN, Longhi-Balbinot DT, Guazelli
CFS, Navarro SA, Zarpelon AC, Casagrande R, Arakawa NS and Verri WA
Jr: Chapter 7-Sesquiterpene lactones: Structural diversity and
perspectives as anti-inflammatory molecules. Studies Natu Products
Chemistry. 49:243–264. 2016. View Article : Google Scholar
|
|
27
|
Ivanescu B, Miron A and Corciova A:
Sesquiterpene lactones from Artemisia Genus: Biological activities
and methods of analysis. J Anal Methods Chem. 2015:2476852015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ooko E, Saeed MEM, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Efferth T: Molecular pharmacology and
pharmacogenomics of artemisinin and its derivatives in cancer
cells. Curr Drug Targets. 7:407–421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia J, Qin Y, Zhang L, Guo C, Wang Y, Yue
X and Qian J: Artemisinin inhibits gallbladder cancer cell lines
through triggering cell cycle arrest and apoptosis. Mol Med Report.
13:4461–4468. 2016. View Article : Google Scholar
|
|
31
|
Zhang M, Wang L, Liu W, Wang T, De Sanctis
F, Zhu L, Zhang G, Cheng J, Cao Q, Zhou J, et al: Targeting
inhibition of accumulation and function of Myeloid-derived
suppressor cells by artemisinin via PI3K/AKT, mTOR, and MAPK
pathways enhances Anti-PD-L1 immunotherapy in melanoma and liver
tumors. J Immunol Res. 2022:22534362022.PubMed/NCBI
|
|
32
|
Tyagi N, Sharma GN, Shrivastava B, Saxena
P and Kumar N: Medicinal plants: Used in Anti-cancer treatment. Int
J Res Dev Pharmacy Life Sci. 6:2732–2739. 2017.
|
|
33
|
He GN, Bao NR, Wang S, Xi M, Zhang TH and
Chen FS: Ketamine induces ferroptosis of liver cancer cells by
targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des Devel Ther.
15:3965–3978. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
AbouAitah K and Lojkowski W: Delivery of
natural agents by means of mesoporous silica nanospheres as a
promising anticancer strategy. Pharmaceutics. 13:1432021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weifeng T, Feng S, Xiangji L, Changqing S,
Zhiquan Q, Huazhong Z, Peining Y, Yong Y, Mengchao W, Xiaoqing J
and Wan-Yee L: Artemisinin inhibits in vitro and in vivo invasion
and metastasis of human hepatocellular carcinoma cells.
Phytomedicine. 18:158–162. 2011. View Article : Google Scholar
|
|
36
|
Zhang CZ, Zhang H, Yun J, Chen GG and Lai
PB: Dihydroartemisinin exhibits antitumor activity toward
hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol.
83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vandewynckel YP, Laukens D, Geerts A,
Vanhove C, Descamps B, Colle I, Devisscher L, Bogaerts E, Paridaens
A, Verhelst X, et al: Therapeutic effects of artesunate in
hepatocellular carcinoma: repurposing an ancient antimalarial
agent. Eur J Gastroenterol Hepatol. 26:861–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ilamathi M, Santhosh S and
Sivaramakrishnan V: Artesunate as an anti-cancer agent targets
stat-3 and favorably suppresses hepatocellular carcinoma. Curr Top
Med Chem. 16:2453–2463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu J, Liu S, Xing Y, Min M, Runpeng Z, Jun
X and Dong H: Artesunate promotes sensitivity to sorafenib in
hepatocellular carcinoma. Biochem Biophysical Res Commun.
519:41–45. 2019. View Article : Google Scholar
|
|
40
|
Dong W, Ma WJ, Ma YB, Li FJ, Li TZ, Wang
YC, He XF, Geng CN, Zhang XM and Chen JJ: Guaiane-type
sesquiterpenoid dimers from Artemisia zhongdianensis and
antihepatoma carcinoma activity via the p38MAPK pathway. Chin J
Chemistry. 41:2453–2468. 2023. View Article : Google Scholar
|
|
41
|
Gao Z, Ma WJ, Li TZ, Ma YB, Hu J, Huang
XY, Geng CA, He XF, Zhang XM and Chen JJ: Artemidubolides A-T,
cytotoxic unreported guaiane-type sesquiterpenoid dimers against
three hepatoma cell lines from Artemisia dubia. Phytochemistry.
202:1132992022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Q, Zhang T, Ke CQ, Tang C, Yao S, Lin
L and Ye Y: Sesquiterpene lactone dimers from Artemisia
lavandulifolia inhibit interleukin-1β production in macrophages
through activating autophagy. Bioorg Chem. 105:1044512020.
View Article : Google Scholar
|
|
43
|
Su L, Zhang X, Ma Y, Geng C, Huang X, Hu
J, Li T, Tang S, Shen C, Gao Z, et al: New guaiane-type
sesquiterpenoid dimers from Artemisia atrovirens and their
antihepatoma activity. Acta Pharm Sin B. 11:1648–1666. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rasul A, Di J, Millimouno FM, Malhi M,
Tsuji I, Ali M, Li J and Li X: Reactive oxygen species mediate
isoalantolactone-induced apoptosis in human prostate cancer cells.
Molecules. 18:9382–9396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu ZC, Hui XG, Huo L, Sun DX, Peng W,
Zhang Y, Li XB, Ma T, Li WH, Liang J and Sun ZQ: Antiproliferative
effects of isoalantolactone in human liver cancer cells are
mediated through caspase-dependent apoptosis, ROS generation,
suppression of cell migration and invasion and targeting
Ras/Raf/MEK signalling pathway. Acta Biochim Pol. 69:299–304.
2022.PubMed/NCBI
|
|
46
|
Gu W, Zhao H, Yuan H and Zhao S:
Dehydrocostus lactone reduced malignancy of HepG2 human
hepatocellular carcinoma cells via Down-regulation of the PI3K/AKT
signaling pathway. Bull Exp Biol Med. 174:360–365. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Si H, Genna B, Zhuang X, Wang J, Burenbatu
B, Feng Q and Wang H: DaHuangWan targets EGF signaling to inhibit
the proliferation of hepatoma cells. PLoS One. 15:e02314662020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mao J, Yi M, Tao Y, Huang Y and Chen M:
Costunolide isolated from Vladimiria souliei inhibits the
proliferation and induces the apoptosis of HepG2 cells. Mol Med
Rep. 19:1372–1379. 2019.
|
|
49
|
Cui YQ, Liu YJ and Zhang F: The
suppressive effects of Britannin (Bri) on human liver cancer
through inducing apoptosis and autophagy via AMPK activation
regulated by ROS. Biochem Biophys Res Commun. 497:916–923. 2018.
View Article : Google Scholar
|
|
50
|
Wang B, Zhou TY, Nie CH, Wan DL and Zheng
SS: Bigelovin, a sesquiterpene lactone, suppresses tumor growth
through inducing apoptosis and autophagy via the inhibition of mTOR
pathway regulated by ROS generation in liver cancer. Biochem
Biophys Res Commun. 499:156–163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chai T, Meng XH, Wang CB, Wang K, Ma LM,
Shi YP and Yang JL: Narjatamolide, an unusual homoguaiane
sesquiterpene lactone from Nardostachys jatamansi. J Org Chem.
86:11006–11010. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shimizu Y, Polavarapu R, Eskla KL,
Nicholson CK, Koczor CA, Wang R, Lewis W, Shiva S, Lefer DJ and
Calvert JW: Hydrogen sulfide regulates cardiac mitochondrial
biogenesis via the activation of AMPK. J Mol Cell Cardiol.
116:29–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu W, Ge K, Guo Y, Zhu W and Liu L:
ROS-dependent cell death Induced by parthenolide in human hepatoma
cell hepG2. Open Access Library J. 7:1–18. 2020.
|
|
54
|
Zhai JD, Li D, Long J, Zhang HL, Lin JP,
Qiu CJ, Zhang Q and Chen Y: Biomimetic semisynthesis of arglabin
from parthenolide. J Org Chem. 77:7103–7107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W,
Yang M, Fan H, Long J, Tong Z, et al: Guaianolide sesquiterpene
lactones, a source to discover agents that selectively inhibit
acute myelogenous leukemia stem and progenitor cells. J Med Chem.
55:8757–8769. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li
F, Yang Z, Lu Y, Liu W, et al: Mecheliolide elicits ROS-mediated
ERS driven immunogenic cell death in hepatocellular carcinoma.
Redox Biol. 54:1023512022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhong J, Gong W, Chen J, Qing Y, Wu S, Li
H, Huang C, Chen Y, Wang Y, Xu Z, et al: Micheliolide alleviates
hepatic steatosis in db/db mice by inhibiting inflammation and
promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR
signaling. Int Immunopharmacol. 59:197–208. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhao Y, Chen SJ, Wang JC, Niu HX, Jia QQ,
Chen XW, Du XY, Lu L, Huang B, Zhang Q, et al: Sesquiterpene
lactones inhibit advanced oxidation protein product-induced MCP-1
expression in podocytes via an IKK/NF-κB-dependent mechanism. Oxid
Med Cell Longev. 2015:9340582015. View Article : Google Scholar
|
|
59
|
Xu H, Wang J, Wang C, Chang G, Lin Y,
Zhang H, Zhang H, Li Q and Pang T: Therapeutic effects of
micheliolide on a murine model of rheumatoid arthritis. Mol Med
Rep. 11:489–493. 2015. View Article : Google Scholar
|
|
60
|
Bian M, Fan R, Zhao S and Liu W: Targeting
the thioredoxin system as a strategy for cancer therapy:
Miniperspective. J Med Chem. 62:7309–7321. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
An Y, Guo W, Li L, Xu C, Yang D, Wang S,
Lu Y, Zhang Q, Zhai J, Fan H, et al: Micheliolide derivative DMAMCL
inhibits glioma cell growth in vitro and in vivo. PLoS One.
10:e01162022015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yao S, Ye J, Yin M and Yu R: DMAMCL exerts
antitumor effects on hepatocellular carcinoma both in vitro and in
vivo. Cancer Lett. 483:87–97. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sulistyani N: Screening of anticancer,
hepatoprotective and nephroprotective effects of ethanol extract of
Elephantopus scaber L. Pak J Pharm Sci. 33:901–907. 2020.PubMed/NCBI
|
|
64
|
Fu L, Pei D, Yu M, Shang H, Si JG, Zhang
HW, Zhang T and Zou ZM: New phenolic acids from the whole herb of
Elephantopus scaber Linn. and their anti-inflammatory activity. Nat
Prod Res. 35:3667–3674. 2021. View Article : Google Scholar
|
|
65
|
Ariesta I and Sukma MG: Extract of
Elephantopus scaber as therapy for insulin resistance by decreasing
damage of heart and Liver in STZ-Na induced diabetic rats (Rattus
novergicus). Am Heart J. 229:1682020. View Article : Google Scholar
|
|
66
|
Divya GS, Mansoor KP, Rasheed SP and Kumar
A: PPAR gamma agonists: An effective strategy for cancer treatment.
J Pharm Sci Innov. 2:1–3. 2013. View Article : Google Scholar
|
|
67
|
Bich Ngoc TT, Hoai Nga NT, My Trinh NT,
Thuoc TL and Phuong Thao DT: Elephantopus mollis Kunth extracts
induce antiproliferation and apoptosis in human lung cancer and
myeloid leukemia cells. J Ethnopharmacol. 263:1132222020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Beeran AA, Maliyakkal N, Rao CM and Udupa
N: The enriched fraction of Elephantopus scaber Triggers apoptosis
and inhibits Multi-drug resistance transporters in human epithelial
cancer cells. Pharmacogn Mag. 11:257–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Mehmood T, Maryam A, Zhang H, Li Y, Khan M
and Ma T: Deoxyelephantopin induces apoptosis in HepG2 cells via
oxidative stress, NF-κB inhibition and mitochondrial dysfunction.
Biofactors. 43:63–72. 2017. View Article : Google Scholar
|
|
70
|
Bai M, Chen JJ, Xu W, Dong SH, Liu QB, Yao
GD, Lin B, Huang XX and Song SJ: Germacranolides from Elephantopus
scaber L. and their cytotoxic activities. Phytochemistry.
178:1124792020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bai M, Chen JJ, Xu W, Dong SH, Liu QB, Lin
B, Huang XX, Yao GD and Song SJ: Elephantopinolide AP,
germacrane-type sesquiterpene lactones from Elephantopus scaber
induce apoptosis, autophagy and G2/M phase arrest in hepatocellular
carcinoma cells. Eur J Med Chem. 198:1123622020. View Article : Google Scholar
|
|
72
|
Mehmood T, Maryam A, Tian X, Khan M and Ma
T: Santamarine inhibits NF-кB and STAT3 activation and induces
apoptosis in HepG2 liver cancer cells via oxidative stress. J
Cancer. 8:3707–3717. 2017. View Article : Google Scholar :
|
|
73
|
Kim JK, Cho IJ, Kim EO, Lee DG, Jung DH,
Ki SH, Ku SK and Kim SC: Hemistepsin A inhibits T0901317-induced
lipogenesis in the liver. BMB Rep. 54:1062021. View Article : Google Scholar :
|
|
74
|
Kim JK, Han NR, Park SM, Jegal KH, Jung
JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, et al: Hemistepsin A
alleviates liver fibrosis by inducing apoptosis of activated
hepatic stellate cells via inhibition of nuclear factor-κB and Akt.
Food Chem Toxicol. 135:1110442020. View Article : Google Scholar
|
|
75
|
Kim JK, Cho IJ, Kim EO, Jung DH, Ku SK and
Kim SC: The effects of Hemistepta lyrata Bunge (Bunge) fractionated
extract on liver X receptor α-dependent lipogenic genes in
hepatocyte-derived cells. Herbal Formula Sci. 28:255–269. 2020.
|
|
76
|
Kim JK, Lee JE, Jung EH, Jung JY, Jung DH,
Ku SK, Cho IJ and Kim SC: Hemistepsin A ameliorates acute
inflammation in macrophages via inhibition of nuclear factor-κB and
activation of nuclear factor erythroid 2-related factor 2. Food
Chem Toxicol. 111:176–188. 2018. View Article : Google Scholar
|
|
77
|
Baek SY, Hwang UW, Suk HY and Kim YW:
Hemistepsin a inhibits cell proliferation and induces G0/G1-Phase
arrest, cellular senescence and apoptosis via the AMPK and p53/p21
signals in human hepatocellular carcinoma. Biomolecules.
10:7132020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Cho IJ, Kim JK, Kim EO, Park SM, Kim SC,
Ki SH and Ku SK: Hemistepsin A induces apoptosis of hepatocellular
carcinoma cells by downregulating STAT3. Int J Mol Sci.
22:47432021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Nibret E, Youns M, Krauth-Siegel RL and
Wink M: Biological activities of x1anthatin from Xanthium
strumarium leaves. Phytother Res. 25:1883–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kovács A, Vasas A, Forgo P, Réthy B, Zupkó
I and Hohmann J: Xanthanolides with antitumour activity from
Xanthium italicum. Z Naturforsch C J Biosci. 64:343–349. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ramírez-Erosa I, Huang Y, Hickie RA,
Sutherland RG and Barl B: Xanthatin and xanthinosin from the burs
of Xanthium strumarium L. as potential anticancer agents. Can J
Physiol Pharmacol. 85:1160–1172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shi T, Zhang L, Cheng Q, Yu JS, Liu J,
Shen YJ, Feng XJ and Shen YX: Xanthatin induces apoptosis by
activating endoplasmic reticulum stress in hepatoma cells. Eur J
Pharmacol. 843:1–11. 2019. View Article : Google Scholar
|
|
83
|
Kuck K, Jürgenliemk G, Lipowicz B and
Heilmann J: Sesquiterpenes from myrrh and their ICAM-1 inhibitory
activity in vitro. Molecules. 26:422020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Li L, Zheng BB, Ma LS, Sun X, Chang JJ,
Xie WD and Li X: Telekin suppresses human hepatocellular carcinoma
cells in vitro by inducing G2/M phase arrest via the p38 MAPK
signaling pathway. Acta Pharmacol Sin. 35:1311–1322. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Su LH, Ma WJ, Ma YB, Li TZ, Geng CA, Dong
W, He XF, Zhang XM and Chen JJ: Artemiprincepsolides A-F, Novel
Germacrane-guaiane and Eudesmane-guaiane Sesquiterpenoid Dimers
from Artemisia princeps and Their Antihepatoma Activity. Chin J
Chem. 41:2648–2656. 2023. View Article : Google Scholar
|
|
86
|
Wu H, Wu H, Wang W, Liu TT, Qi MG, Feng
JC, Li XY and Liu Y: Insecticidal activity of sesquiterpene
lactones and monoterpenoid from the fruits of Carpesium
abrotanoides. Industrial Crops Products. 92:77–83. 2016. View Article : Google Scholar
|
|
87
|
Wang F, Yang K, Ren FC and Liu JK:
Sesquiterpene lactones from Carpesium abrotanoides. Fitoterapia.
80:21–24. 2009. View Article : Google Scholar
|
|
88
|
Lee J, Min B, Lee S, Na M, Kwon B, Lee C,
Kim Y and Bae K: Cytotoxic sesquiterpene lactones from Carpesium
abrotanoides. Planta Med. 68:745–747. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yang C, Yuan C and Jia Z: Xanthanolides,
Germacranolides, and Other Constituents from Carpesium longifolium.
J Nat Prod. 66:1554–1557. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Yan Y, Chen J, Peng M, Zhang X, Feng E, Li
Q, Guo B, Ding X, Zhang Y and Tang L: Sesquiterpenes from Carpesium
faberi triggered ROS-induced apoptosis and protective autophagy in
hepatocellular carcinoma cells. Phytochemistry. 214:1138052023.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lo Cantore P, Iacobellis NS, De Marco A,
Capasso F and Senatore F: Antibacterial activity of Coriandrum
sativum L. and Foeniculum vulgare Miller var. vulgare (Miller)
essential oils. J Agric Food Chem. 52:7862–7866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Emamghoreishi M, Khasaki M and Aazam MF:
Coriandrum sativum: Evaluation of its anxiolytic effect in the
elevated plus-maze. J Ethnopharmacol. 96:365–370. 2005. View Article : Google Scholar
|
|
93
|
Bickers D, Calow P, Greim H, Hanifin JM,
Rogers AE, Saurat JH, Sipes IG, Smith RL and Tagami H: A
toxicologic and dermatologic assessment of linalool and related
esters when used as fragrance ingredients. Food Chem Toxicol.
41:919–942. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Usta J, Kreydiyyeh S, Knio K, Barnabe P,
Bou-Moughlabay Y and Dagher S: Linalool decreases HepG2 viability
by inhibiting mitochondrial complexes I and II, increasing reactive
oxygen species and decreasing ATP and GSH levels. Chem Biol
Interact. 180:39–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Simamora A, Timotius KH, Yerer MB,
Setiawan H and Mun'im A: Xanthorrhizol, a potential anticancer
agent, from Curcuma xanthorrhiza Roxb. Phytomedicine.
105:1543592022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Tee TT, Cheah YH, Meenakshii N, Mohd
Sharom MY and Azimahtol Hawariah LP: Xanthorrhizol induced DNA
fragmentation in HepG2 cells involving Bcl-2 family proteins.
Biochem Biophys Res Commun. 420:834–838. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Fonseca DV, Salgado PR, de Carvalho FL,
Salvadori MG, Penha AR, Leite FC, Borges CJ, Piuvezam MR, Pordeus
LC, Sousa DP and Almeida RN: Nerolidol exhibits antinociceptive and
anti-inflammatory activity: Involvement of the GABAergic system and
proinflammatory cytokines. Fundam Clin Pharmacol. 30:14–22. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Krist S, Banovac D, Tabanca N, Wedge DE,
Gochev VK, Wanner J, Schmidt E and Jirovetz L: Antimicrobial
activity of nerolidol and its derivatives against airborne microbes
and further biological activities. Nat Prod Commun. 10:143–148.
2015.PubMed/NCBI
|
|
99
|
Chan WK, Tan LT, Chan KG, Lee LH and Goh
BH: Nerolidol: A sesquiterpene alcohol with Multi-faceted
pharmacological and biological activities. Molecules. 21:5292016.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Biazi BI, Zanetti TA, Baranoski A,
Corveloni AC and Mantovani MS: Cis-Nerolidol induces endoplasmic
reticulum stress and cell death in human hepatocellular carcinoma
cells through extensive CYP2C19 and CYP1A2 oxidation. Basic Clin
Pharmacol Toxicol. 121:334–341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Sharifi-Rad M, Nazaruk J, Polito L,
Morais-Braga MFB, Rocha JE, Coutinho HDM, Salehi B, Tabanelli G,
Montanari C, Del Mar Contreras M, et al: Matricaria genus as a
source of antimicrobial agents: From farm to pharmacy and food
applications. Microbiol Res. 215:76–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Eddin LB, Jha NK, Goyal SN, Agrawal YO,
Subramanya SB, Bastaki SMA and Ojha S: Health benefits,
pharmacological effects, molecular mechanisms, and therapeutic
potential of α-bisabolol. Nutrients. 14:13702022. View Article : Google Scholar
|
|
103
|
Kreuger MRO, Grootjans S, Biavatti MW,
Vandenabeele P and D'Herde K: Sesquiterpene lactones as drugs with
multiple targets in cancer treatment: Focus on parthenolide.
Anticancer Drugs. 23:883–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng
P, Zhao S, Chen M, Yang G and He G: Anti-tumor effect of germacrone
on human hepatoma cell lines through inducing G2/M cell cycle
arrest and promoting apoptosis. Eur J Pharmacol. 698:95–102. 2013.
View Article : Google Scholar
|
|
105
|
Liu YY, Zheng Q, Fang B, Wang W, Ma FY,
Roshan S, Banafa A, Chen MJ, Chang JL, Deng XM, et al: Germacrone
induces apoptosis in human hepatoma HepG2 cells through inhibition
of the JAK2/STAT3 signalling pathway. Med Sci. 33:339–345.
2013.
|
|
106
|
Na-Bangchang K, Plengsuriyakam T and
Karbwang J: Research and development of atractylodes lancea (Thunb)
DC. As a promising candidate for cholangiocarcinoma
chemotherapeutics. Evid Based Complement Alternat Med.
2017:59292342017. View Article : Google Scholar
|
|
107
|
Cheng Y, Mai JY, Hou TL, Ping J and Chen
JJ: Antiviral activities of atractylon from Atractylodis Rhizoma.
Mol Med Rep. 14:3704–3710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Meng H, Li GY, Dai RH, Ma Y, Zhang K,
Zhang C, Li X and Wang J: Chemical constituents of Atractylodes
chinensis (DC.) koidz. Biochem Syst Ecol. 38:1220–1223. 2010.
View Article : Google Scholar
|
|
109
|
Cheng Y, Chen T, Yang X, Xue J and Chen J:
Atractylon induces apoptosis and suppresses metastasis in hepatic
cancer cells and inhibits growth in vivo. Cancer Manag Rese.
11:5883–5894. 2019. View Article : Google Scholar
|
|
110
|
Cheng Y, Ping J, Chen J, Fu Y, Zhao H and
Xue J: Molecular mechanism of atractylon in the invasion and
migration of hepatic cancer cells based on high-throughput
sequencing. Mol Med Rep. 25:1122022. View Article : Google Scholar :
|
|
111
|
Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ,
Chang LH, Chang CM, Hsu SL, Teng CL and Wu CC: Supercritical carbon
dioxide extraction of aromatic turmerone from Curcuma longa Linn.
Induces apoptosis through reactive oxygen species-triggered
intrinsic and extrinsic pathways in human hepatocellular carcinoma
HepG2 cells. J Agric Food Chem. 60:9620–9630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Abu-Izneid T, Rauf A, Shariati MA, Khalil
AA, Imran M, Rebezov M, Uddin MS, Mahomoodally MF and Rengasamy
KRR: Sesquiterpenes and their derivatives-natural anticancer
compounds: An update. Pharmacol Res. 161:1051652020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Fraga BM: Natural sesquiterpenoids. Nat
Prod Rep. 30:1226–1264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wu L, Huang X, Kuang Y, Xing Z, Deng X and
Luo Z: Thapsigargin induces apoptosis in adrenocortical carcinoma
by activating endoplasmic reticulum stress and the JNK signaling
pathway: An in vitro and in vivo study. Drug Des Devel Ther.
13:2787–2798. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Andersen TB, López CQ, Manczak T, Martinez
K and Simonsen HT: Thapsigargin-from Thapsia L. to mipsagargin.
Molecules. 20:6113–6127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Brennen WN, Rosen DM, Wang H, Isaacs JT
and Denmeade SR: Targeting carcinoma-associated fibroblasts within
the tumor stroma with a fibroblast activation protein-activated
prodrug. J Natl Cancer Inst. 104:1320–1334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Denmeade SR, Mhaka AM, Rosen DM, Brennen
WN, Dalrymple S, Dach I, Olesen C, Gurel B, Demarzo AM, Wilding G,
et al: Engineering a prostate-specific membrane antigen-activated
tumor endothelial cell prodrug for cancer therapy. Sci Transl Med.
4:140ra862012. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Qu Z, Liu H, Zhang Z, Zheng P, Zhao S and
Hou W: Phytochemistry and pharmacology of sesquiterpenoids from
Atractylodes DC. Genus Rhizomes. Molecules. 29:13792024. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Tian XH, Hong LL, Jiao WH and Lin HW:
Natural sesquiterpene quinone/quinols: Chemistry, biological
activity, and synthesis. Nat Prod Reps. 40:718–749. 2023.
View Article : Google Scholar
|
|
120
|
Shulha O and Zidorn C: Sesquiterpene
lactones and their precursors as chemosystematic markers in the
tribe Cichorieae of the Asteraceae revisited: An update
(2008-2017). Phytochemistry. 163:149–177. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Xu K, Feng ZM, Yang YN, Jiang JS and Zhang
PC: Eight new eudesmane-and eremophilane-type sesquiterpenoids from
Atractylodes lancea. Fitoterapia. 114:115–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Ding HY, Wu YC and Linc HC: Phytochemical
and pharmacological studies on Chinese changzhu. J Chin Chem Soc.
47:561–566. 2000. View Article : Google Scholar
|
|
123
|
Nakai Y, Kido T, Hashimoto K, Kase Y,
Sakakibara I, Higuchi M and Sasaki H: Effect of the rhizomes of
Atractylodes lancea and its constituents on the delay of gastric
emptying. J Ethnopharmacol. 84:51–55. 2003. View Article : Google Scholar
|
|
124
|
Guo W, XU B, Meng Q, Zheng B, Li X, Liu M
and Du XD: Anti-tumor effect of Hinesol on liver cancer via
downregulating MEK/ERK and NF-κB pathway in SMMC-7721 and LM3cells.
Chin J Pharmacol Toxicol. 32:282. 2018.
|
|
125
|
Lobo R, Prabhu KS and Shirwaikar A:
Curcuma zedoaria Rosc. (White turmeric): A review of its chemical,
pharmacological and ethnomedicinal properties. J Pharm Pharmacol.
61:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Mao Z, Zhong L, Zhuang X, Liu H and Peng
Y: Curcumenol targeting YWHAG inhibits the pentose phosphate
pathway and enhances antitumor effects of cisplatin. Evid Based
Complement Alternat Med. 2022:39889162022. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Wen Y, Han J, Chen J, Dong J, Xia Y, Liu
J, Jiang Y, Dai J, Lu J, Jin G, et al: Plasma mi RNA s as early
biomarkers for detecting hepatocellular carcinoma. Int J Cancer.
137:1679–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Yerukala Sathipati S and Ho SY: Novel
miRNA signature for predicting the stage of hepatocellular
carcinoma. Scie Rep. 10:144522020. View Article : Google Scholar
|
|
129
|
Sartorius K, Sartorius B, Winkler C,
Chuturgoon A and Makarova J: The biological and diagnostic role of
miRNA's in hepatocellular carcinoma. Front Biosci (Landmark Ed).
23:1701–1720. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
130
|
Qadir MI and Rizvi SZ: miRNA in
hepatocellular carcinoma: Pathogenesis and therapeutic approaches.
Crit Rev Eukaryot Gene Expr. 27:355–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Elhefnawi M, Salah Z and Soliman B: The
promise of miRNA replacement therapy for hepatocellular carcinoma.
Curr Gene Ther. 19:290–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang X, Gao J, Zhou B, Xie J, Zhou G and
Chen Y: Identification of prognostic markers for hepatocellular
carcinoma based on miRNA expression profiles. Life Sci.
232:1165962019. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Li D, Zhang J and Li J: Role of miRNA
sponges in hepatocellular carcinoma. Clin Chim Acta. 500:10–19.
2020. View Article : Google Scholar
|
|
134
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhang R, Zhong L, Sun K, Liu J, Wang Q,
Mao D, Fang G and Long F: A study on curcumol influencing
proliferation and apoptosis of hepatocellular carcinoma cells
through DJ-1/PTEN/PI3K/AKT Pathway. Biomed Res Int.
2022:99127762022. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kirana C, McIntosh GH, Record IR and Jones
GP: Antitumor activity of extract of Zingiber aromaticum and its
bioactive sesquiterpenoid zerumbone. Nutr Cancer. 45:218–225. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wani NA, Zhang B, Teng K, Barajas JM,
Motiwala T, Hu P, Yu L, Brüschweiler R, Ghoshal K and Jacob ST:
Reprogramming of glucose metabolism by zerumbone suppresses
hepatocarcinogenesis. Mol Cancer Res. 16:256–268. 2018. View Article : Google Scholar
|
|
138
|
Samad NA, Abdul AB, Rahman HS, Rasedee A,
Tengku Ibrahim TA and Keon YS: Zerumbone suppresses angiogenesis in
HepG2 cells through inhibition of matrix metalloproteinase-9,
vascular endothelial growth factor, and vascular endothelial growth
factor receptor expressions. Pharmacogn Mag. 13(Suppl 4):
S731–S736. 2017.
|
|
139
|
Abdul ABH, Al-Zubairi AS, Tallan ND, Wahab
SIA, Zain ZNM, Ruslay S and Syam MM: Anticancer activity of natural
compound (zerumbone) extracted from Zingiber zerumbet in human HeLa
cervical cancer cells. Int J Pharmacol. 4:1602008. View Article : Google Scholar
|
|
140
|
Sakinah SA, Handayani ST and Hawariah LP:
Zerumbone induced apoptosis in liver cancer cells via modulation of
Bax/Bcl-2 ratio. Cancer Cell Int. 7:42007. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Taha MME, Abdul AB, Abdullah R, Ibrahim
TA, Abdelwahab SI and Mohan S: Potential chemoprevention of
diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted
hepatocarcinogenesis by zerumbone from the rhizomes of the
subtropical ginger (Zingiber zerumbet). Chem Biol Interact.
186:295–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Bora KS and Sharma A: Phytochemical and
pharmacological potential of Medicago sativa: A review. Pharm Biol.
49:211–220. 2011. View Article : Google Scholar
|
|
143
|
Rustaiyan A and Masoudi S: Chemical
constituents and biological activities of Iranian Artemisia
species. Phytochemistry Lett. 4:440–447. 2011. View Article : Google Scholar
|
|
144
|
He ZZ, Yan JF, Song ZJ, Ye F, Liao X, Peng
SL and Ding LS: Chemical constituents from the aerial parts of
Artemisia minor. J Nat Prod. 72:1198–1201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Martínez MJA, Del Olmo LMB, Ticona LA and
Benito PB: The Artemisia L. genus: A review of bioactive
sesquiterpene lactones. Stud Natu Products Chem. 37:43–65. 2012.
View Article : Google Scholar
|
|
146
|
Suresh J, Mahesh NM, Ahuja J and Santilna
KS: Review on Artemisia nilagirica (Clarke) pamp. J Biol Active
Products Nat. 1:97–104. 2011.
|
|
147
|
He X, Ma W, Hu J, Li T, Geng C, Ma Y, Wang
M, Yang K, Zhang X and Chen JJ: Diverse structures and antihepatoma
effect of sesquiterpenoid dimers from Artemisia eriopoda by
AKT/STAT signaling pathway. Signal Transduct Target Ther. 8:642023.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Li X, Chen Q, Liu J, Lai S, Zhang M, Zhen
T, Hu H, Gao X, Wong AST and Zeng JZ: Orphan nuclear receptor Nur77
mediates the lethal endoplasmic reticulum stress and therapeutic
efficacy of cryptomeridiol in hepatocellular carcinoma. Cells.
11:38702022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Yu X, Yang FQ, Li SP, Gao JL, Hu G, Lao
SC, Conceição EL, Fung KP, Wangl YT and Lee SM: Furanodiene induces
G2/M cell cycle arrest and apoptosis through MAPK signaling and
mitochondria-caspase pathway in human hepatocellular carcinoma
cells. Cancer Biol Ther. 6:1044–1050. 2014.
|
|
150
|
Yang F, Chen WD, Deng R, Li DD, Wu KW,
Feng GK, Li HJ and Zhu XF: Hirsutanol A induces apoptosis and
autophagy via reactive oxygen species accumulation in breast cancer
MCF-7 cells. J Pharmacol Sci. 119:214–220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Yang F, Chen WD, Deng R, Zhang H, Tang J,
Wu KW, Li DD, Feng GK, Lan WJ, Li HJ and Zhu XF: Hirsutanol A, a
novel sesquiterpene compound from fungus Chondrostereum sp.,
induces apoptosis and inhibits tumor growth through
mitochondrial-independent ROS production: Hirsutanol A inhibits
tumor growth through ROS production. J Transl Med. 11:322013.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhang J, Mao Y, Hou L and Cui X: The
effect of beta-elemene on alpha-tubulin polymerization in human
hepatoma HepG2 cells. Chin J Cancer Res. 25:770–776. 2013.
|
|
153
|
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo
A and Wang W: Assessing the quality of RCTs on the effect of
beta-elemene, one ingredient of a Chinese herb, against malignant
tumors. Contemp Clin Trials. 27:70–82. 2006. View Article : Google Scholar
|
|
154
|
Sun Y, Liu G, Zhang Y, Zhu H, Ren Y and
Shen YM: Synthesis and in vitro anti-proliferative activity of
β-elemene monosubstituted derivatives in HeLa cells mediated
through arrest of cell cycle at the G1 phase. Bioorg Med Chem.
17:1118–1124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Wu B, Jiang Y, Zhu F, Sun D and Huang H:
Demethylation effects of elemene on the GSTP1 gene in HCC cell line
QGY7703. Oncol Lett. 11:2545–2551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Qin Y, Guo Y, Wei W, Wang B, Jin H, Sun J,
Qi J, Ren S and Zuo Y: Anti-tumor effect of β-elemene in murine
hepatocellular carcinoma cell line H22 depends on the level of
c-Met downregulation. Biomedicine Preventive Nutr. 2:91–98. 2012.
View Article : Google Scholar
|
|
157
|
Ni G, Shi GR, Zhang D, Fu NJ, Yang HZ,
Chen XG and Yu DQ: Cytotoxic Lignans and Sesquiterpenoids from the
Rhizomes of Acorus tatarinowii. Planta Medica. 82:632–638. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chen JJ, Wei HB, Xu YZ, Hu SC and Gao K:
Senedensiscins A-F: Six new eudesmane sesquiterpenoid glucosides
from Senecio densiserratus. Tetrahedron. 69:10598–10603. 2013.
View Article : Google Scholar
|
|
159
|
Yang ML, Chen JJ, Wei HB and Gao K:
Cytotoxic sesquiterpenoids from Senecio densiserratus.
Phytochemistry Lett. 16:236–240. 2016. View Article : Google Scholar
|
|
160
|
Tsevegsuren N, Edrada RA, Lin W, Ebel R,
Torre C, Ortlepp S, Wray V and Proksch P: Biologically active
natural products from Mongolian medicinal plants Scorzonera
divaricata and Scorzonera pseudodivaricata. J Nat Prod. 70:962–967.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Wu Q, He XF, Jiang CX, Zhang W, Shi ZN, Li
HF and Zhu Y: Two novel bioactive sulfated guaiane sesquiterpenoid
salt alkaloids from the aerial parts of Scorzonera divaricata.
Fitoterapia. 124:113–119. 2018. View Article : Google Scholar
|
|
162
|
Shang C, Ma YB, Wang Y, He XF, Li TZ and
Chen JJ: Artemongolins A-K, undescribed germacrane-guaiane
sesquiterpenoid dimers from Artemisia mongolica and their
antihepatoma activities. Arch Pharm Res. 46:782–794. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Wang MF, Li TZ, Ma YB, Ma WJ, Wang YC, Li
FJ and Chen JJ: Artemyriantholides A-K, guaiane-type
sesquiterpenoid dimers from Artemisia myriantha var. pleiocephala
and their antihepatoma activity. Phytochemistry. 222:1141002024.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
He XF, Ma YB, Li TZ and Chen JJ: Highly
oxygenated guaiane-type sesquiterpene lactones from Artemisia
sacrorum and their antihepatoma activity. Phytochemistry.
217:1139302024. View Article : Google Scholar
|
|
165
|
Wang X, Li TZ, Ma YB, Ma WJ, Xue D and
Chen JJ: Synthesis and antihepatoma activity of guaianolide dimers
derived from lavandiolide I. Bioorg Med Chem Lett. 104:1297082024.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Fang JY and Richardson BC: The MAPK
signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Meloche S and Pouysségur J: The ERK1/2
mitogen-activated protein kinase pathway as a master regulator of
the G1-to S-phase transition. Oncogene. 26:3227–3239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yang F, Li J, Zhu J, Wang D, Chen S and
Bai X: Hydroxysafflor yellow A inhibits angiogenesis of
hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling
pathway in H22 tumor-bearing mice. Eur J Pharmacol. 754:105–114.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Cusimano A, Foderà D, D'Alessandro N,
Lampiasi N, Azzolina A, Montalto G and Cervello M: Potentiation of
the antitumor effects of both selective cyclooxygenase-1 and
cyclooxygenase-2 inhibitors in human hepatic cancer cells by
inhibition of the MEK/ERK pathway. Cancer Biol Ther. 6:1457–1464.
2007. View Article : Google Scholar
|
|
170
|
Wang XD, Meng FC and Mao JX: Progress of
natural sesquiterpenoids in the treatment of hepatocellular
carcinoma. Front Oncol. 14:14452222024. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Li Y, Wang T, Sun Y, Huang T and Li C, Fu
Y, Li Y and Li C: p53-mediated PI3K/AKT/mTOR pathway played a role
in PtoxDpt-induced EMT inhibition in liver cancer cell
lines. Oxid Med Cell Longev. 2019:25314932019.
|
|
172
|
Kahraman DC, Kahraman T and Cetin-Atalay
R: Targeting PI3K/Akt/mTOR pathway identifies differential
expression and functional role of IL8 in liver cancer stem cell
enrichment. Mol Cancer Ther. 18:2146–2157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Luedde T and Schwabe RF: NF-κB in the
liver-linking injury, fibrosis and hepatocellular carcinoma. Nat
Rev Gastroenterol Hepatol. 8:108–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Wilson CL, Jurk D, Fullard N, Banks P,
Page A, Luli S, Elsharkawy AM, Gieling RG, Chakraborty JB, Fox C,
et al: NFκB1 is a suppressor of neutrophil-driven hepatocellular
carcinoma. Nat Commun. 6:68182015. View Article : Google Scholar
|
|
175
|
Lee C and Cheung ST: STAT3: An emerging
therapeutic target for hepatocellular carcinoma. Cancers.
11:16462019. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Boland ML, Chourasis AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Lee KH, Huang ES, Piantadosi C, Pagano JS
and Geissman TA: Cytotoxicity of sesquiterpene lactones. Cancer
Res. 31:1649–1654. 1971.PubMed/NCBI
|
|
178
|
Lopez-Anton N, Hermann C, Murillo R,
Merfort I, Wanner G, Vollmar AM and Dirsch VM: Sesquiterpene
lactones induce distinct forms of cell death that modulate human
Monocyte-derived macrophage responses. Apoptosis. 12:141–153. 2007.
View Article : Google Scholar
|
|
179
|
Bai Z, Yao C, Zhu J, Xie Y, Ye XY, Bai R
and Xie T: Anti-tumor drug discovery based on natural product
β-elemene: Anti-tumor mechanisms and structural modification.
Molecules. 26:14992021. View Article : Google Scholar
|
|
180
|
Xie T, Li CL and Wang SL: Basic research
progress of natural anticancer target drugs of elemene liposomes
series. Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:507–512. 2014.In
Chinese. PubMed/NCBI
|
|
181
|
Zhai B, Zeng Y, Zeng Z, Zhang N, Li C,
Zeng Y, You Y, Wang S, Chen X, Sui X and Xie T: Drug delivery
systems for elemene, its main active ingredient β-elemene, and its
derivatives in cancer therapy. Int J Nanomedicine. 13:6279–6296.
2018. View Article : Google Scholar :
|
|
182
|
Xie T, Cl L, Wang SL, Zeng ZW, Wang F and
Zhao R: Advances in the research of Elemene Liposome series
targeted anticancer natural drugs. Chin J Integr Trad West Med.
34:507–512. 2014.
|
|
183
|
Li H, Xu K, Pian G and Sun S: Artesunate
and sorafenib: Combinatorial inhibition of liver cancer cell
growth. Oncol Lett. 18:4735–4743. 2019.PubMed/NCBI
|
|
184
|
Yao X, Zhao CR, Yin H, Wang K and Gao JJ:
Synergistic antitumor activity of sorafenib and artesunate in
hepatocellular carinoma cells. Acta Pharmacol Sin. 41:1609–1620.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Alven S and Aderibigbe BA: Nanoparticles
formulations of artemisinin and derivatives as potential
therapeutics for the treatment of cancer, leishmaniasis and
malaria. Pharmaceutics. 12:7482020. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Pan XW, Huang JS, Liu SR, Shao YD, Xi JJ,
He RY, Shi TT, Zhuang RX and Bao JF: Evaluation of the liver
targeting and anti-liver cancer activity of artesunate-loaded and
glycyrrhetinic acid-coated nanoparticles. Exp Ther Med. 26:5162023.
View Article : Google Scholar
|
|
187
|
Hermida MA, Kumar JD and Leslie NR: GSK3
and its interactions with the PI3K/AKT/mTOR signalling network. Adv
Biol Regul. 65:5–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Tang W, Chen Z, Zhang W, Cheng Y, Zhang B,
Wu F, Wang Q, Wang S, Rong D, Reiter FP, et al: The mechanisms of
sorafenib resistance in hepatocellular carcinoma: Theoretical basis
and therapeutic aspects. Signal Transduct Target Ther. 5:872020.
View Article : Google Scholar : PubMed/NCBI
|
